NEW YORK (GenomeWeb) – Researchers at the Hartwig Medical Foundation and the Center for Personalized Cancer Treatment in the Netherlands have launched a drug repurposing study to match patients' molecular alterations with targeted drugs, regardless of whether the drug was designed for the specific tumor type.

The project is an attempt to address the rising healthcare costs associated with new cancer drugs and to identify biomarkers associated with those drugs to ensure patients are being treated appropriately, according to the investigators.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.

Sep
07
Sponsored by
PerkinElmer

This webinar will address improvements in the library prep workflow for small RNA sequencing in serum and plasma.